These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 36057389)

  • 41. Human Papillomavirus Vaccination Trends Among Adolescents: 2015 to 2020.
    Lu PJ; Yankey D; Fredua B; Hung MC; Sterrett N; Markowitz LE; Elam-Evans LD
    Pediatrics; 2022 Jul; 150(1):. PubMed ID: 35730334
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tanzania's human papillomavirus (HPV) vaccination program: Community awareness, feasibility, and acceptability of a national HPV vaccination program, 2019.
    Li AJ; Manzi F; Kyesi F; Makame Y; Mwengee W; Fleming M; Mkopi A; Mmbaga S; Lyimo D; Loharikar A
    Vaccine; 2022 Mar; 40 Suppl 1(Suppl 1):A38-A48. PubMed ID: 34229889
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Current Trends in HPV Vaccine Uptake: Wisconsin and United States, 2016-2019.
    Cull Weatherer A; Pritzl SL; Kerch S; Li Z; LoConte NK
    WMJ; 2021 Apr; 120(1):62-65. PubMed ID: 33974768
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The impact of a Facebook campaign among mothers on HPV vaccine uptake among their daughters: A randomized field study.
    Chodick G; Teper GR; Levi S; Kopel H; Kleinbort A; Khen E; Schejter E; Shalev V; Stein M; Lewis N
    Gynecol Oncol; 2021 Jan; 160(1):106-111. PubMed ID: 33162176
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human Papillomavirus Infection and Vaccination.
    Valentino K; Poronsky CB
    J Pediatr Nurs; 2016; 31(2):e155-66. PubMed ID: 26586310
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Associations between population based voting trends during the 2016 US presidential election and adolescent vaccination rates.
    Suryadevara M; Bonville CA; Cibula DA; Domachowske JB; Suryadevara AC
    Vaccine; 2019 Feb; 37(9):1160-1167. PubMed ID: 30691983
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Human Papillomavirus Vaccine as an Anticancer Vaccine: Collaborative Efforts to Promote Human Papillomavirus Vaccine in the National Comprehensive Cancer Control Program.
    Townsend JS; Steele CB; Hayes N; Bhatt A; Moore AR
    J Womens Health (Larchmt); 2017 Mar; 26(3):200-206. PubMed ID: 28263672
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human papillomavirus (HPV) vaccine uptake among a community-recruited sample of gay, bisexual, and other men who have sex with men in the three largest cities in Canada from 2017 to 2019.
    Grewal R; Deeks SL; Hart TA; Cox J; De Pokomandy A; Grennan T; Lambert G; Moore D; Brisson M; Coutlée F; Gaspar M; George C; Grace D; Jollimore J; Lachowsky NJ; Nisenbaum R; Ogilvie G; Sauvageau C; Tan DHS; Yeung A; Burchell AN
    Vaccine; 2021 Jun; 39(28):3756-3766. PubMed ID: 34074547
    [TBL] [Abstract][Full Text] [Related]  

  • 49. What explains the different rates of human papillomavirus vaccination among adolescent males and females in the United States?
    Choi Y; Eworuke E; Segal R
    Papillomavirus Res; 2016 Dec; 2():46-51. PubMed ID: 29074185
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Human papillomavirus vaccine uptake among males 11-26 years in United States: findings from the National Health and Nutrition Examination Survey, 2011-2012.
    Pierre-Victor D; Mukherjee S; Bahelah R; Madhivanan P
    Vaccine; 2014 Nov; 32(49):6655-8. PubMed ID: 25446825
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Strategies to improve human papillomavirus vaccination rates among adolescents in family practice settings in the United States: A systematic review.
    Eisenhauer L; Hansen BR; Pandian V
    J Clin Nurs; 2021 Feb; 30(3-4):341-356. PubMed ID: 33270305
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Trends in Human Papillomavirus-Associated Cancers, Demographic Characteristics, and Vaccinations in the US, 2001-2017.
    Liao CI; Francoeur AA; Kapp DS; Caesar MAP; Huh WK; Chan JK
    JAMA Netw Open; 2022 Mar; 5(3):e222530. PubMed ID: 35294540
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human Papillomavirus Vaccination and Human Papillomavirus-Associated Cancer Rates Within Florida Counties.
    Staras SAS; Huo T; Rothbard SM; Hall JM; Cho HD; Guo Y; Richardson E; Salloum RG; Thompson LA; Silver NL; Shenkman EA
    Am J Prev Med; 2021 Dec; 61(6):812-820. PubMed ID: 34384654
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinician communication strategies associated with increased uptake of the human papillomavirus (HPV) vaccine: A systematic review.
    Constable C; Ferguson K; Nicholson J; Quinn GP
    CA Cancer J Clin; 2022 Nov; 72(6):561-569. PubMed ID: 35969145
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Socioeconomic disadvantage and human papillomavirus (HPV) vaccination uptake.
    Kurani S; MacLaughlin KL; Jacobson RM; St Sauver JL; Jenkins GD; Fan C; Jacobson DJ; Inselman J; Zhu X; Griffin JM; Finney Rutten LJ
    Vaccine; 2022 Jan; 40(3):471-476. PubMed ID: 34916103
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human papillomavirus vaccination series initiation and completion, 2008-2009.
    Dorell CG; Yankey D; Santibanez TA; Markowitz LE
    Pediatrics; 2011 Nov; 128(5):830-9. PubMed ID: 22007006
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human papillomavirus vaccine series completion in boys before and after recommendation for routine immunization.
    Ackerson B; Hechter R; Sidell M; Sy LS; Slezak J; Chao C; Patel N; Tseng HF; Jacobsen S
    Vaccine; 2017 Feb; 35(6):897-902. PubMed ID: 28094077
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of human papillomavirus vaccination on racial/ethnic disparities in vaccine-type human papillomavirus prevalence among 14-26 year old females in the U.S.
    Hirth J; McGrath CJ; Kuo YF; Rupp RE; Starkey JM; Berenson AB
    Vaccine; 2018 Nov; 36(50):7682-7688. PubMed ID: 30377066
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Completion of the human papillomavirus vaccine series among insured females between 2006 and 2009.
    Hirth JM; Tan A; Wilkinson GS; Berenson AB
    Cancer; 2012 Nov; 118(22):5623-9. PubMed ID: 22544681
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study.
    Tabrizi SN; Brotherton JM; Kaldor JM; Skinner SR; Liu B; Bateson D; McNamee K; Garefalakis M; Phillips S; Cummins E; Malloy M; Garland SM
    Lancet Infect Dis; 2014 Oct; 14(10):958-66. PubMed ID: 25107680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.